A couple of weeks ago, I highlighted bad sales and booking news from Dutch semiconductor equipment manufacturer ASML (ASML -2.42%), and pointed out how this might make investors in American peer Lam Research (LRCX -4.26%) want to sell their stock ahead of earnings.
Now earnings are out, and today, Lam Research stock is down 5% through 10:35 a.m. ET.
Image source: Getty Images.
It turns out I was right to worry about Lam Research stock -- but for the life of me, I don't know why!
Two weeks ago, ASML's earnings report showed sales growth of less than 1%, and a slowdown in bookings foreshadowing a slowdown in demand for artificial intelligence (AI) chips -- or at least for the machines that make them. But based on Lam Research's last-night report, it now seems Lam is not suffering anywhere near the ill-effects that ASML is.
To the contrary.
In Q2, analysts forecast Lam would earn $1.21 per share on $5 billion in sales. In fact, the company reported generally accepted accounting principles (GAAP) profit of $1.35 and sales of $5.2 billion. Sales grew a respectable 10% year over year, and earning surged 31%. Management even delivered great guidance -- $1.10 to $1.30 in profit for Q3, and sales between $4.9 billion and $5.5 billion, both numbers much better than Wall Street had forecast.
Mind you, I'm still a little leery of Lam's valuation. Priced near 27 times trailing earnings, and even more expensive when valued on free cash flow, the stock looks risky to me if Lam can't deliver on the guidance it gave. Still, 31% earnings growth in Q2 goes a long way to allaying those concerns.
Lam stock may not be cheap enough to buy -- but I wouldn't call it a "sell" either.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。